Skip to main content
OpenTrials
Completed

NCT Number: NCT07403695

Photobiomodulation Therapy on Nerve Repair Using Red and Infra-red Diode Lasers

Peripheral nerve injury is a major concern that drastically affects the patient's quality of life. Nowadays, several treatment options are available, including medical treatments, surgical intervention, and others. However, the trending photobiomodulation effect of laser therapy is attracting many dental professionals due to its promising results on nerve rehabilitation.

The study is intended to assess and compare laser photobiomodulation using red and infra-red diode lasers on the repair of nerve injury in the maxillofacial region.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Alexandria university

Alexandria, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient aged range from 20-50 years old
  • Patient suffering from nerve injury in the maxillofacial region for a period of 6 months or more without improvement.

Exclusion criteria

  • 1- Patient had undergone micro-neurosurgery to correct neurosensory deficit.

Treatment and study plan

635 wavelength

Device

635 wavelength laser

980 wavelength

Device

980 wavelength laser

Primary outcomes

  1. visual analogue scale

    Time frame: 1,2,4,8,12 weeks

    from 1- 10

    1 means no pain 10 means worst pain

Secondary outcomes

  1. clinical neurosensory test

    Time frame: 2,4,8,12 weeks

    from S0 to S4 S0 means worst neurosensory function S4 full recovery for neurosensory function

Sponsors and collaborators

Lead sponsor

mona oraby

Other

Registry information

Official study title

Comparison Between Photobiomodulation Therapy on Nerve Repair Using Red and Infra-red Diode Lasers in Maxillofacial Region (A Randomized Clinical Trial)

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Feb 11, 2026
Registry last updated
Feb 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.